Valuentum Exclusive Analysis for the Discerning Investor

Symbol Keyword

Member Login Email Password Join Now Forgotten Password Newsletters/Portfolios View Current and Archived Dividend Growth Newsletters View Current and Archived Best Ideas Newsletters Valuentum's Dividend Growth Newsletter Portfolio Valuentum's Best Ideas Newsletter Portfolio Order the Exclusive Publication! View Current and Archived Exclusive Editions Order the High Yield Dividend Newsletter! Dividend Cushion Efficacy Calculation Dividend-Adjusted Leverage White Paper Stock Screens How to Filter Data in Microsoft Excel Like a Pro Download Weekly Stock Screener (xls) -- login required The Quarterly DataScreener Products & Tools Financial Advisor (GOLD LEVEL) Publications DCF Valuation Model Template Order Value Trap Order Value Trap, second edition Value Trap Order PDF Copy Order Paperback Copy Presentation BookLife Review BlueInk Review Foreword Review Readers' Favorite Review Axiom Bronze Praise The Buying Index, VBI Value and Momentum Within Stocks, Too (2017) The Case for the Valuentum Style of Investing (2012) Investing's Odd Couple: Value and Momentum (2013) Stock-Selection Methodology, the Valuentum Buying Index (2011) Why Valuentum Buying Index Ratings Matter (2014) Dividend Changes Dividend Increases/Decreases for the Week of November 8 Dividend Increases/Decreases for the Week of November 1 Dividend Increases/Decreases for the Week of October 25 Dividend Increases/Decreases for the Week of October 18 Dividend Increases/Decreases for the Week of October 11 Dividend Increases/Decreases for the Week of October 4

Results 61 - 70 of 132 for mye. (0.23 seconds) Three Notable Pending FDA Approvals Image Source: Brandon Giesbrecht. The final... Healthcare Earnings Update Featuring Johnson and Johnson, Cardinal Health and Abbott Labs Image Source: Johnson & Johnson. The upcoming deluge... Earnings Update on European Big Pharma Featuring Novartis, Sanofi, and AstraZeneca Image Source: Sanofi. The drug industry is a global... A Review of Johnson and Johnson’s Pharmaceutical Division Image Source: J&J. Let’s take a deep dive... Our Overview on Merck in Light of Recent Clinical Events Image Source: Merck. Clinical data reads can have an... Johnson & Johnson in Transition Mode Image Source: Johnson & Johnson. Shares of... Merck’s Dominance in Immuno-Oncology Expands Once Again Image Source: Merck. Merck simply blew away the... The Promise of CAR-T Therapy Image Source: Gilead. The medical field,... Roche Continues to Underwhelm We like cutting-edge, novel therapies as they have a... Novartis: Business Transformation in Progress Image shown: The performance of Novartis’ stock... prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | next